Roos E. Eilers
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation.
Journal: Gastro hep advances
Published: June 04, 2025
Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 16, 2024
Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 22, 2023
The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice.
Journal: Toxicology and applied pharmacology
Published: March 08, 2023
Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 02, 2022
Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.
Journal: Cellular and molecular gastroenterology and hepatology
Published: June 11, 2020
β-Catenin Directs Nuclear Factor-κB p65 Output via CREB-Binding Protein/p300 in Human Airway Smooth Muscle.
Journal: Frontiers in immunology
Published: February 09, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026